HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outpatient interstitial thermoradiotherapy.

AbstractBACKGROUND:
Hyperthermia enhances the cytocidal effect of ionizing radiation. Several pilot studies demonstrated that the combination of interstitial hyperthermia and interstitial radiotherapy (interstitial thermoradiotherapy) is safe and effective. However, these studies mainly utilized low dose rate brachytherapy, and therefore, required hospitalization. With the availability of median or high dose rate brachytherapy devices, we piloted a study to evaluate the feasibility, toxicity and efficacy of interstitial thermoradiotherapy performed in an outpatient setting.
METHODS:
Between 1989 and 1993, 27 patients with a diagnosis of carcinoma of the head and neck region (n = 23), carcinoma of the breast (n = 3), or malignant melanoma (n = 1) received 1 or 2 sessions of interstitial thermoradiotherapy. Median patient age was 66 years (range: 37-83 years). Treatment consisted of 60 minutes of 915 MHz microwave interstitial hyperthermia, followed by iridium-192 seed implants, either by Micro-Selectron HDR (10-12 Gray [Gy] in 8.5-21 minutes) or high activity (5-8 mCi per seed) seeds (10-15 Gy in 2-4 hours). In addition to interstitial temperature measurements, a real-time thermal camera was used to monitor the surface temperature spatial distribution. power supply and/or position of interstitial microwave applicators was adjusted when appropriate. All but one patient also received external beam irradiation prior to implants.
RESULTS:
Patients tolerated treatments well although 16 (59%) of them required analgesics during hyperthermia sessions. Skin blisters or ulcerations occurred in only 6 (22%), and all but 2 healed. Complete response occurred in 24 patients (89%), partial in 3 (11%). With a median follow up of 16 months (range: 3-43 months), the 2-year actuarial local control rate was 74%.
CONCLUSIONS:
The results of this study indicate that outpatient interstitial thermoradiotherapy is convenient, safe, and efficacious for treating human neoplasms.
AuthorsD J Lee, R Mayer, L Hallinan
JournalCancer (Cancer) Vol. 77 Issue 11 Pg. 2363-70 (Jun 01 1996) ISSN: 0008-543X [Print] United States
PMID8635108 (Publication Type: Journal Article)
Topics
  • Actuarial Analysis
  • Adult
  • Aged
  • Aged, 80 and over
  • Ambulatory Care
  • Brachytherapy (adverse effects)
  • Breast Neoplasms (radiotherapy, therapy)
  • Calorimetry
  • Carcinoma (radiotherapy, therapy)
  • Combined Modality Therapy
  • Diathermy (adverse effects)
  • Feasibility Studies
  • Female
  • Head and Neck Neoplasms (radiotherapy, therapy)
  • Humans
  • Male
  • Melanoma (radiotherapy, therapy)
  • Microwaves (adverse effects, therapeutic use)
  • Middle Aged
  • Neoplasms (mortality, radiotherapy, therapy)
  • Photography (instrumentation)
  • Pilot Projects
  • Radiotherapy Dosage
  • Radiotherapy, High-Energy
  • Skin Temperature
  • Survival Analysis
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: